During the past decade, Highland General Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 55 clinical trials were completed, i.e. on average, 1100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 13 clinical trials were completed. i.e. 650% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Highland General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 41 trials, followed by "SWOG Cancer Research Network" with 23 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Highland General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "North Central Cancer Treatment Group" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Highland General Hospital" are "Breast Cancer" (17 trials), "Lung Cancer" (11 trials), "HIV Infections" (9 trials), "Recurrent Breast Carcinoma" (6 trials) and "Stage IIA Breast Cancer AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Highland General Hospital" in a lesser frequency.

Most popular intervention types in "Highland General Hospital" are "Drug" (88 trials), "Other" (46 trials), "Biological" (33 trials), "Radiation" (18 trials) and "Procedure" (11 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (28 trials), "Bevacizumab" (16 trials), "Paclitaxel" (13 trials), "Quality-of-Life Assessment" (12 trials) and "Carboplatin" (11 trials). Other intervention names were less common.

The vast majority of trials in "Highland General Hospital" are 71 trials for "All" genders, 29 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Highland General Hospital". undefined are not yet recruiting, 2 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Highland General Hospital, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Highland General Hospital, 4 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".